,trastuzumab deruxtecan
daiichi sankyo,astrazeneca
[]
 discussing updated safety db-03. no new safety signals. t-dxd with more nausea, vomiting and fatigue. #asco22 
Breast Medical Oncologist @dukecancer. Clinical investigator. Mom of ???. Tweet=own opinion.